Published in Bone on February 29, 2008
Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev Biol (2009) 1.24
Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice. BMC Dev Biol (2010) 1.11
Fibroblast growth factor signaling in skeletal development and disease. Genes Dev (2015) 1.04
Molecular (SNP) analyses of overlapping hemizygous deletions of 10q25.3 to 10qter in four patients: evidence for HMX2 and HMX3 as candidate genes in hearing and vestibular function. Am J Med Genet A (2009) 1.03
Molecular analysis of coronal perisutural tissues in a craniosynostotic rabbit model using polymerase chain reaction suppression subtractive hybridization. Plast Reconstr Surg (2011) 0.78
Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis. PLoS One (2014) 0.78
FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts. Stem Cell Rev (2012) 0.77
The molecular and cellular basis of Apert syndrome. Intractable Rare Dis Res (2013) 0.75
Modeling craniofacial and skeletal congenital birth defects to advance therapies. Hum Mol Genet (2016) 0.75
Taking cell-matrix adhesions to the third dimension. Science (2001) 15.21
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology (1980) 5.59
Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell (2003) 4.56
Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol (2003) 4.55
Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol (1990) 4.27
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev (2002) 4.16
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet (1995) 4.01
A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell (2006) 3.90
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A (1998) 3.27
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell (2000) 2.99
The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials (2005) 2.20
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci U S A (2000) 2.13
Birth prevalence study of the Apert syndrome. Am J Med Genet (1992) 2.10
The BMP antagonist noggin regulates cranial suture fusion. Nature (2003) 2.09
Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol (2000) 2.08
In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng (2003) 2.05
Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci U S A (1999) 1.99
Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development (2005) 1.93
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet (2004) 1.92
Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet (1995) 1.85
Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet (1998) 1.83
A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone (2003) 1.50
Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng (2004) 1.50
Studying actin-dependent processes in tissue culture. Nat Rev Mol Cell Biol (2002) 1.49
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
New indirect method for estimating the birth prevalence of the Apert syndrome. Int J Oral Maxillofac Surg (1992) 1.20
Biomimetic artificial ECMs stimulate bone regeneration. J Biomed Mater Res A (2006) 1.19
Manipulations in hydrogel degradation behavior enhance osteoblast function and mineralized tissue formation. Tissue Eng (2006) 1.11
Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Miner Res (1996) 1.08
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome. J Biol Chem (2004) 1.07
Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci (2005) 1.03
Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydroxypropylmethylcellulose hydrogel. Biomaterials (2005) 0.93
Cell biology: tumour jailbreak. Nature (2003) 0.88
Forcing the third dimension. Cell (2006) 0.80
The Apert syndrome hand: pathologic anatomy and clinical manifestations. Plast Reconstr Surg (1997) 0.79
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. J Cell Physiol (2005) 0.79
Exome sequencing identifies the cause of a mendelian disorder. Nat Genet (2009) 32.06
Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet (2002) 3.43
Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater (2007) 2.92
Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion. Nat Genet (2005) 2.77
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet (2004) 2.65
Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials (2005) 2.44
Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet (2005) 2.17
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A (2008) 1.99
Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development (2005) 1.93
Human cartilage repair with a photoreactive adhesive-hydrogel composite. Sci Transl Med (2013) 1.87
Association between IRF6 and nonsyndromic cleft lip with or without cleft palate in four populations. Genet Med (2007) 1.75
Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. Tissue Eng (2006) 1.72
Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet (2002) 1.71
TCOF1 mutations excluded from a role in other first and second branchial arch-related disorders. Am J Med Genet (2002) 1.69
De minimis risk: a proposal for a new category of research risk. Am J Bioeth (2011) 1.65
Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. Am J Hum Genet (2012) 1.64
Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. Am J Hum Genet (2012) 1.63
In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release (2002) 1.61
The molecular mechanism underlying Roberts syndrome involves loss of ESCO2 acetyltransferase activity. Hum Mol Genet (2008) 1.58
Adult stem cell driven genesis of human-shaped articular condyle. Ann Biomed Eng (2004) 1.56
Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Community Genet (2011) 1.55
GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat (2009) 1.52
Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng (2004) 1.50
Effects of three-dimensional culture and growth factors on the chondrogenic differentiation of murine embryonic stem cells. Stem Cells (2005) 1.44
Differential response of adult and embryonic mesenchymal progenitor cells to mechanical compression in hydrogels. Stem Cells (2007) 1.42
Designing zonal organization into tissue-engineered cartilage. Tissue Eng (2007) 1.38
Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials (2006) 1.38
The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. Am J Hum Genet (2003) 1.37
Functional characterization of connexin43 mutations found in patients with oculodentodigital dysplasia. Circ Res (2005) 1.31
Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. J Cell Physiol (2007) 1.29
Characterization of ocular motor deficits in congenital facial weakness: Moebius and related syndromes. Brain (2014) 1.25
Photocrosslinkable polysaccharides based on chondroitin sulfate. J Biomed Mater Res A (2004) 1.20
Oculodentodigital dysplasia connexin43 mutations result in non-functional connexin hemichannels and gap junctions in C6 glioma cells. J Cell Sci (2006) 1.19
Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation. PLoS One (2012) 1.18
Dear old dad. Sci Aging Knowledge Environ (2004) 1.18
Gene expression in pharyngeal arch 1 during human embryonic development. Hum Mol Genet (2005) 1.16
A novel syndrome caused by the E410K amino acid substitution in the neuronal β-tubulin isotype 3. Brain (2013) 1.15
Synthesis and characterization of a novel degradable phosphate-containing hydrogel. Biomaterials (2003) 1.13
Bioinspired nanofibers support chondrogenesis for articular cartilage repair. Proc Natl Acad Sci U S A (2012) 1.12
Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev Dyn (2010) 1.11
Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice. BMC Dev Biol (2010) 1.11
Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-mediated microenvironment. Tissue Eng Part A (2008) 1.10
Bioresponsive phosphoester hydrogels for bone tissue engineering. Tissue Eng (2005) 1.09
Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. J Biochem Mol Biol (2006) 1.08
A novel heterozygous deletion in the EVC2 gene causes Weyers acrofacial dysostosis. Hum Genet (2006) 1.07
Mutations in HOXD13 underlie syndactyly type V and a novel brachydactyly-syndactyly syndrome. Am J Hum Genet (2007) 1.05
Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study. J Community Genet (2013) 1.05
FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models. PLoS One (2011) 1.04
The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination. Biomaterials (2013) 1.03
OTX2 mutations contribute to the otocephaly-dysgnathia complex. J Med Genet (2012) 1.02
A novel dysmorphic syndrome with open calvarial sutures and sutural cataracts maps to chromosome 14q13-q21. Hum Genet (2003) 1.02
Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev Dyn (2010) 1.02
Parental origin of mutations in sporadic cases of Treacher Collins syndrome. Eur J Hum Genet (2003) 1.02
Evidence that TGFA influences risk to cleft lip with/without cleft palate through unconventional genetic mechanisms. Hum Genet (2009) 1.01
Differential parental transmission of markers in RUNX2 among cleft case-parent trios from four populations. Genet Epidemiol (2008) 1.01
Tissue-specific responses to aberrant FGF signaling in complex head phenotypes. Dev Dyn (2012) 1.01
Genomic, cDNA and embryonic expression analysis of zebrafish IRF6, the gene mutated in the human oral clefting disorders Van der Woude and popliteal pterygium syndromes. Gene Expr Patterns (2005) 1.01
In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg (2007) 1.01
Engineering musculoskeletal tissues with human embryonic germ cell derivatives. Stem Cells (2010) 1.01
An analysis of the integration between articular cartilage and nondegradable hydrogel using magnetic resonance imaging. J Biomed Mater Res B Appl Biomater (2006) 1.00
Metabolic changes in mesenchymal stem cells in osteogenic medium measured by autofluorescence spectroscopy. Stem Cells (2006) 1.00
Magnetic resonance imaging of chondrocytes labeled with superparamagnetic iron oxide nanoparticles in tissue-engineered cartilage. Tissue Eng Part A (2009) 0.99
CD271 as a marker for mesenchymal stem cells in bone marrow versus umbilical cord blood. Cells Tissues Organs (2013) 0.98
Characterizing ECM production by cells encapsulated in hydrogels. Methods Mol Biol (2009) 0.97
The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. PLoS Genet (2009) 0.97
Cochleosaccular dysplasia associated with a connexin 26 mutation in keratitis-ichthyosis-deafness syndrome. Laryngoscope (2006) 0.97
Genetic basis of potential therapeutic strategies for craniosynostosis. Am J Med Genet A (2010) 0.97
Mesenchymal stem cell stimulation of tissue growth depends on differentiation state. Stem Cells Dev (2010) 0.96
HOXB1 founder mutation in humans recapitulates the phenotype of Hoxb1-/- mice. Am J Hum Genet (2012) 0.96
Gold nanorod-based localized surface plasmon resonance biosensor for sensitive detection of hepatitis B virus in buffer, blood serum and plasma. Biosens Bioelectron (2010) 0.96
Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet (2003) 0.94
Stem cells in musculoskeletal engineered tissue. Curr Opin Biotechnol (2009) 0.94
Excessive running induces cartilage degeneration in knee joints and alters gait of rats. J Orthop Res (2012) 0.93
Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis. Birth Defects Res A Clin Mol Teratol (2011) 0.92
From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome. Dis Model Mech (2013) 0.92
Biodegradable and photocrosslinkable polyphosphoester hydrogel. Biomaterials (2005) 0.92
A modified chondroitin sulfate aldehyde adhesive for sealing corneal incisions. Invest Ophthalmol Vis Sci (2005) 0.92
Embryonic germ cells are capable of adipogenic differentiation in vitro and in vivo. Tissue Eng Part A (2009) 0.92
Size of the embryoid body influences chondrogenesis of mouse embryonic stem cells. J Tissue Eng Regen Med (2008) 0.91
Genome wide study of maternal and parent-of-origin effects on the etiology of orofacial clefts. Am J Med Genet A (2012) 0.90
Intravenous application of CD271-selected mesenchymal stem cells during fracture healing. J Orthop Trauma (2014) 0.90
Role of bone morphogenetic proteins and their antagonists in healing of bone fracture. Front Biosci (Landmark Ed) (2009) 0.90
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. J Clin Invest (2012) 0.90
Association between genes on chromosome 4p16 and non-syndromic oral clefts in four populations. Eur J Hum Genet (2010) 0.89
An injectable adipose matrix for soft-tissue reconstruction. Plast Reconstr Surg (2012) 0.89
Noninvasive mitochondrial imaging in live cell culture. Photochem Photobiol (2005) 0.88
A twisted hand: bHLH protein phosphorylation and dimerization regulate limb development. Bioessays (2005) 0.88
Hyaluronic acid-binding scaffold for articular cartilage repair. Tissue Eng Part A (2012) 0.88
The influence of biological motifs and dynamic mechanical stimulation in hydrogel scaffold systems on the phenotype of chondrocytes. Biomaterials (2010) 0.88
A novel ZRS mutation leads to preaxial polydactyly type 2 in a heterozygous form and Werner mesomelic syndrome in a homozygous form. Hum Mutat (2014) 0.87
The differential effect of scaffold composition and architecture on chondrocyte response to mechanical stimulation. Biomaterials (2008) 0.87
Heterotopic ossifications in a mouse model of albright hereditary osteodystrophy. PLoS One (2011) 0.87